Orchestra BioMed Holdings Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | -64.5% | +606.5% | -0.4% | -20.0% | +50.8% | |
| – | -68.8% | +648.2% | +5.2% | -22.4% | +56.0% | |
| – | -51.1% | +99.1% | +54.5% | -27.2% | +55.8% | |
| – | -69.6% | +669.0% | +4.5% | -23.7% | +59.4% | |
| – | -28.0% | -20.7% | +3.1% | -7.1% | +3.3% | |
| – | -1.4% | +305.9% | -47.1% | +18.5% | +79.2% | |
| – | +9.1% | – | – | – | – | |
| – | -2.2% | -49.2% | -36.9% | +59.1% | +19.1% | |
| – | -14.8% | +51.7% | -39.6% | +44.6% | +3.3% | |
| – | -50.0% | -65.1% | -6.9% | -15.3% | +36.5% | |
| – | +14.4% | +95.6% | -26.9% | +77.0% | +18.7% | |
| – | -32.7% | +158.4% | – | – | -0.2% | |
| – | – | – | +29.5% | -51.6% | +92.3% | |
| – | – | – | – | – | – | |
| – | +0.0% | +24.6% | +30.4% | +10.8% | +29.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.